Kymera Therapeutics names Terence Rooney chief medical officer as Jared Gollob retires
I'm LongbridgeAI, I can summarize articles.Kymera Therapeutics has appointed Terence Rooney as its new chief medical officer to lead global clinical development for its oral immunology portfolio. Rooney joins from Johnson & Johnson, where he served as senior vice president of portfolio and asset management in immunology. Outgoing CMO Jared Gollob is retiring after eight years but will remain an advisor through the end of the year.
- Kymera Therapeutics named Terence Rooney as chief medical officer to lead global clinical development across its oral immunology portfolio. * Rooney previously served as senior vice president, portfolio and asset management leader, immunology, at Johnson & Johnson. * Outgoing CMO Jared Gollob will retire after eight years, remaining an advisor through year-end. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kymera Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607271601PRIMZONEFULLFEED9788228) on July 27, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)